Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Pliant Therapeutics (PLRX)

Pliant Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PLRX
DateTimeSourceHeadlineSymbolCompany
02/01/202513:00GlobeNewswire Inc.Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PLRXPliant Therapeutics Inc
21/11/202413:00GlobeNewswire Inc.Pliant Therapeutics to Participate in Upcoming Investor EventsNASDAQ:PLRXPliant Therapeutics Inc
18/11/202423:00GlobeNewswire Inc.Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024NASDAQ:PLRXPliant Therapeutics Inc
14/11/202422:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PLRXPliant Therapeutics Inc
07/11/202421:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLRXPliant Therapeutics Inc
07/11/202421:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
07/11/202421:05GlobeNewswire Inc.Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:PLRXPliant Therapeutics Inc
06/11/202413:00GlobeNewswire Inc.Pliant Therapeutics to Participate in the Stifel Healthcare ConferenceNASDAQ:PLRXPliant Therapeutics Inc
17/10/202412:00GlobeNewswire Inc.Pliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in a Late-Breaking Presentation at The Liver Meeting® 2024NASDAQ:PLRXPliant Therapeutics Inc
04/10/202421:34Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PLRXPliant Therapeutics Inc
01/10/202420:35GlobeNewswire Inc.Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical AffairsNASDAQ:PLRXPliant Therapeutics Inc
30/09/202420:45GlobeNewswire Inc.Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PLRXPliant Therapeutics Inc
27/09/202420:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
24/09/202412:00GlobeNewswire Inc.Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical OfficerNASDAQ:PLRXPliant Therapeutics Inc
10/09/202412:00GlobeNewswire Inc.Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024NASDAQ:PLRXPliant Therapeutics Inc
28/08/202412:00GlobeNewswire Inc.Pliant Therapeutics to Participate in Upcoming Investor EventsNASDAQ:PLRXPliant Therapeutics Inc
28/08/202412:00GlobeNewswire Inc.Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of DirectorsNASDAQ:PLRXPliant Therapeutics Inc
26/08/202413:10GlobeNewswire Inc.Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024NASDAQ:PLRXPliant Therapeutics Inc
07/08/202420:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLRXPliant Therapeutics Inc
07/08/202420:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
07/08/202420:05GlobeNewswire Inc.Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:PLRXPliant Therapeutics Inc
06/08/202420:03GlobeNewswire Inc.Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:PLRXPliant Therapeutics Inc
15/07/202415:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLRXPliant Therapeutics Inc
15/07/202412:00GlobeNewswire Inc.Pliant Therapeutics Announces Positive Long-Term Data from the INTEGRIS-PSC Phase 2a Trial Demonstrating Bexotegrast was Well Tolerated at 320 mg with Continued Antifibrotic and Anti-Cholestatic Activity Displayed Across Multiple MeasuresNASDAQ:PLRXPliant Therapeutics Inc
12/07/202422:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
12/07/202422:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
12/07/202422:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
11/07/202420:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
11/07/202420:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
11/07/202420:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLRXPliant Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PLRX